Deep Neural Network for Stroke Patient Gait Analysis and Classification
A Deep Neural Network for Abnormal Gait Patterns Based on Inertial Sensors Among Post-Stroke Patients
1 other identifier
observational
100
1 country
1
Brief Summary
Lower limbs of stroke patients gradually recover through Brunnstrom stages, from initial flaccid status to gradually increased spasticity, and eventually decreased spasticitiy. Throughout this process. after stroke patients can start walking, their gait will show abnormal gait patterns from healthy subjects, including circumduction gait, drop foot, hip hiking and genu recurvatum. For these abnormal gait patterns, rehabilitation methods include ankle-knee orthosis(AFO) or increasing knee/pelvic joint mobility for assistance. Prior to this study, similar research has been done to differentiate stroke gait patterns from normal gait patterns, with an accuracy of over 96%. This study recruits subject who has encountered first ever cerebrovascular incident and can currently walk independently on flat surface without assistance, and investigators record gait information via inertial measurement units strapped to their bilateral ankle, wrist and pelvis to detect acceleration and angular velocity as well as other gait parameters. The IMU used in this study consists of a 3-axis accelerometer, 3-axis gyroscope and 3-axis magnetometer, with a highest sampling rate of 128Hz. Afterwards, investigators use these gait information collected as training data and testing data for a deep neural network (DNN) model and compare clinical observation results by physicians simultaneously, in order to determine whether the DNN model is able to differentiate the types of abnormal gait patterns mentioned above. If this model is applied in the community, investigators hope it is available to early detect abnormal gait patterns and perform early intervention to decrease possibility of fallen injuries. This is a non-invasive observational study and doesn't involve medicine use. Participants are only required to perform walking for 6 minutes without assistance on a flat surface. This risk is extremely low and the only possible risk of this study is falling down during walking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2021
CompletedFirst Posted
Study publicly available on registry
July 20, 2021
CompletedStudy Start
First participant enrolled
July 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedMarch 9, 2022
March 1, 2022
1.8 years
July 8, 2021
March 8, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Deep neural network (DNN) model accuracy of detecting abnormal stroke gait patterns
Investigators compare clinically observed abnormal gait patterns with DNN model detection. Accuracy of the DNN model will be compared to clinical observed data after cross validation, which results in a series of labeling. Investigators compare those labels with actual observed clinical abnormal gait patterns to determine whether DNN is available of identifying abnormal stroke gait patterns accurately.
2 years
Interventions
The OPAL system contains wearable IMUs with a sampling rate of 128 Hz and a resolution of 17.5 bits. Each IMU has a size of about 44mm 40mm 14mm × × and weighs less than 25 gm.
Eligibility Criteria
Investigators focus on unilateral stroke patient over 20 years old who visit Cheng Hsin General Hospital outpatient clinic on a regular basis.
You may qualify if:
- Age over 20 years old with first time stroke
- And affected lower limb Brunnstrom stage III-V
- Functional ambulation category VI
- Participants should be able to walk on flat surface without assistance for 6 minutes
- Mini-Mental State Examination (MMSE) should be over 25 and can comply to orders and cooperate with our study
You may not qualify if:
- Severe central nervous system(CNS)/peripheral nervous system(PNS)neurological disorders apart from stroke
- Patients with high risk of falling down during walking
- Patients who cannot cooperate with testing
- Patients with severe visual/auditory/cognition deficits
- Patients with lower limb fracture within recent 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cheng-Hsin General Hospitallead
- National Taiwan Universitycollaborator
Study Sites (1)
Cheng Hsin General Hospital
Taipei, 112401, Taiwan
Related Publications (3)
Kerrigan DC, Frates EP, Rogan S, Riley PO. Hip hiking and circumduction: quantitative definitions. Am J Phys Med Rehabil. 2000 May-Jun;79(3):247-52. doi: 10.1097/00002060-200005000-00006.
PMID: 10821310BACKGROUNDTrojaniello D, Cereatti A, Pelosin E, Avanzino L, Mirelman A, Hausdorff JM, Della Croce U. Estimation of step-by-step spatio-temporal parameters of normal and impaired gait using shank-mounted magneto-inertial sensors: application to elderly, hemiparetic, parkinsonian and choreic gait. J Neuroeng Rehabil. 2014 Nov 11;11:152. doi: 10.1186/1743-0003-11-152.
PMID: 25388296BACKGROUNDAbaid N, Cappa P, Palermo E, Petrarca M, Porfiri M. Gait detection in children with and without hemiplegia using single-axis wearable gyroscopes. PLoS One. 2013 Sep 4;8(9):e73152. doi: 10.1371/journal.pone.0073152. eCollection 2013.
PMID: 24023825BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Szu-Fu Chen, MD, PHD
Szu-Fu Chen
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2021
First Posted
July 20, 2021
Study Start
July 20, 2021
Primary Completion
May 1, 2023
Study Completion
May 31, 2023
Last Updated
March 9, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
According to the investigator's IRB statement, patient information will only be used in this research and will not be used for other purposes.